NL-OMON55904招募中不适用
Metabolic Imaging to Improve Patient-Specific Therapy Outcome - MAESTRO
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Patients with liver metastasis of gastro-oesophageal cancer, with histological
- •or cytological proof of
- •metastasis or a high suspicion on CT imaging whom are scheduled for first line
- •palliative chemotherapy.
- •2. Informed consent
排除标准
- •Any psychological, familial, sociological or geographical condition potentially
- •hampering adequate informed consent or compliance with the study protocol.
- •Contra-indications for MR scanning, including patients with a pacemaker,
- •cochlear implant or neurostimulator; patients with non-MR compatible metallic
- •implants in their eye, spine, thorax or abdomen; or a non-MR compatible
- •aneurysm clip in their brain; patients with claustrophobia; patient with an
- •abdominal circumference which exceeds MRI-bore circumference.
研究者
相似试验
尚未招募
不适用
Studies on the usefulness of the metabolic imaging against arterial chemoradiation therapy for head and neck cancerhead and neck cancerJPRN-UMIN000005000Tokushima University Hospital Department of Radiology10
进行中（未招募）
1 期
Multiorgan Metabolic imaging response assessment of Abemaciclib: the MiMe-A trialEUCTR2017-000123-28-FRInstitut Jules Bordet185
进行中（未招募）
1 期
Multiorgan Metabolic imaging response assessment of Abemaciclib: the MiMe-A trialesophageal ADC, esophageal SCC, Cholangiocarcinoma, urothelial cancer (progressive after immunotherapy), or endometrial cancerMedDRA version: 20.0Level: LLTClassification code 10055458Term: Esophageal adenocarcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10055476Term: Esophageal squamous cell carcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10008595Term: Cholangiocarcinoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10014735Term: Endometrial cancer NOSSystem Organ Class: 100000004864EUCTR2017-000123-28-BEInstitut Jules Bordet185
招募中
不适用
MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy OutcomesGastrointestinal Cancer MetastaticNCT04534543Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)70
终止
不适用
Metabolic Imaging Predict Histopathologic Response to Preop ChemoXRT for Locally Advanced Rectal CARectal CancerNCT00394615Stanford University15